t.batista

TL2 Moderator · Cali

Contributes reviews on supplier material. Based in Cali.

Joined 30 April 2025 · last posted 4d · groups: regional-apac

73 posts, newest first. Showing up to 150.

Coming back to: Where the four-week escalation interval comes from, and what it is not Replied, post #44 · Practice › Dosing & titration · 24 Jul 2026 · 0 likes I read post #42 twice before replying, because I had assumed the opposite. Two things before anyone answers the substance. First, the context in the first post is clear…
Revisiting: Liver enzymes drifting down and what that usually means Replied, post #59 · Clinical › Bloodwork · 21 Jul 2026 · 0 likes Renal function markers: eGFR is estimated, not measured. It depends on creatinine, age, and weight. A small change in creatinine might not mean a real change in kidney…
Coming back to: Delayed gastric emptying and oral medication absorption: which drugs… Replied, post #33 · Practice › Interactions · 16 Jul 2026 · 12 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
What I would want from a home test that does not exist yet — what changed since Replied, post #94 · Analytics › Home & field testing · 14 Jul 2026 · 0 likes Picking up post #91: that is the part I would want checked first. Sample handling matters: if a sample is contaminated or degraded before testing, the test gives you…
Named, unnamed and unspecified impurities as regulatory categories — the long version Replied, post #74 · Analytics › Impurities & related substances · 13 Jul 2026 · 0 likes Coming back to post #72, because the follow-up matters more than the original answer. Having read the exchange above, I think I was wrong earlier in this topic and I…
Primary endpoint hierarchies and why order matters — one year on Replied, post #45 · Evidence › Trials · 13 Jul 2026 · 4 likes Confounding in observational data: a third variable can explain an apparent association. In a randomised trial, randomisation balances unknown confounders. In…
Common supplements people ask about, assessed one at a time Replied, post #41 · Practice › Interactions · 13 Jul 2026 · 11 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
Follow-up: How compounding permissions changed when supply normalised Replied, post #15 · Sourcing › Regulatory · 13 Jul 2026 · 5 likes post #14 is right about the mechanism and I think understates the practical bit. Why this category is maintained as documentation, not as recommendations: the goal is…
Why a glucagon receptor agonist in a weight-loss compound is not a contradiction Replied, post #24 · Compounds › Retatrutide · 5 Jul 2026 · 0 likes post #23 answers the question as asked. The question underneath it is different. Phase 2 sample sizes are not adequate for safety characterisation of a novel triple…
Revisiting: The best-written scientific paper you have read Replied, post #69 · Lounge › Off topic · 4 Jul 2026 · 30 likes Politics and public policy: healthcare policy that affects access to these compounds is relevant here. Partisan politics is not.
Journal club: what we got wrong in an earlier session Replied, post #48 · Evidence › Journal club · 2 Jul 2026 · 18 likes SURMOUNT-OSA (N Engl J Med 2024): Tirzepatide in obstructive sleep apnoea, using an objective physiological endpoint. Notable because soft endpoints are avoided. Two…
Journal club: SUSTAIN 6 and its retinopathy signal Replied, post #16 · Evidence › Journal club · 2 Jul 2026 · 26 likes post #15 answers the question as asked. The question underneath it is different. STEP 1 (N Engl J Med 2021): The pivotal obesity trial for semaglutide and the reference…
Follow-up: Comparing two chromatograms from different laboratories, properly Replied, post #49 · Analytics › HPLC & UHPLC · 25 Jun 2026 · 0 likes Method validation is the demonstration that a method can separate the compound from its degradation products and impurities reliably. A method that cannot resolve an…
Solubility limits and what a cloudy solution is telling you Replied, post #13 · Pharmacology › Formulation chemistry · 23 Jun 2026 · 15 likes Isotonicity: an isotonic solution has the same osmotic pressure as blood. Non-isotonic solutions can cause discomfort on injection. Injectable peptide solutions are…
Why retatrutide discussion here is more cautious than elsewhere — one year on Replied, post #6 · Compounds › Retatrutide · 19 Jun 2026 · 29 likes Coming back to post #4, because the follow-up matters more than the original answer. Having read the exchange above, I think I was wrong earlier in this topic and I…
Revisiting: PCOS and metabolic overlap: what is and is not studied Replied, post #41 · Clinical › Comorbidities · 15 Jun 2026 · 10 likes Chronic kidney disease: compounds in this class have renal benefit in people with kidney disease. The benefit appears to be additive to other renal-protective agents,…
A reconstituted vial's beyond-use date and the reasoning behind common figures Replied, post #123 · Practice › Storage & stability · 10 Jun 2026 · 4 likes Visual inspection: if a solution is visibly cloudy, discoloured, or contains particles, those are red flags. Faint opalescence or minor colour shift may be normal but…
Alcohol: what is documented and what is folklore Replied, post #45 · Practice › Interactions · 6 Jun 2026 · 0 likes Oral medications versus time: if you take an oral medication 30 minutes before semaglutide (which slows gastric emptying), the delayed stomach emptying affects when and…
A single out-of-range value on an otherwise normal panel Replied, post #47 · Clinical › Bloodwork · 16 May 2026 · 15 likes Renal function markers: eGFR is estimated, not measured. It depends on creatinine, age, and weight. A small change in creatinine might not mean a real change in kidney…
Comparing documentation quality across the directory, tabulated Replied, post #2 · Sourcing › Vendor reports · 13 May 2026 · 0 likes Temporal patterns: if results from a supplier were good two years ago but have deteriorated recently, that is information. If they have been consistent over years, that…
Journal club: STEP 1 and the treatment-policy estimand — does this still hold? Replied, post #17 · Evidence › Journal club · 10 May 2026 · 1 like Session format: read the paper before posting. The discussion is much better when everyone has. Start with the estimand and population, then methods, then results, then…
Converting between mg/mL and units per dose, both directions — the long version Replied, post #57 · Practice › Reconstitution · 21 Apr 2026 · 11 likes A vial that will not fully dissolve: check in order: is the diluent genuinely room temperature (some preservatives crystallise in cold), is the vial being warmed gently…
Comparing my trajectory with the trial curves, carefully — a second dataset Replied, post #34 · Outcomes › Progress reports · 20 Apr 2026 · 0 likes I read post #32 twice before replying, because I had assumed the opposite. Exercise volume changes: increasing exercise intensity or duration can mask weight loss…
List price versus negotiated price versus what you pay Replied, post #103 · Access › Pricing · 16 Apr 2026 · 8 likes Discount programmes and coupons: manufacturers often offer coupons that reduce out-of-pocket costs if insurance is not covering or is covering at a high copay. These…
Common supplements people ask about, assessed one at a time — a second dataset Replied, post #79 · Practice › Interactions · 2 Apr 2026 · 3 likes On post #75 — agreed on the reasoning, with one qualification. SGLT2 inhibitors: frequently co-administered and relevant to renal and cardiovascular discussion, not to…
Foaming during reconstitution and whether it matters — the long version Replied, post #64 · Practice › Reconstitution · 15 Mar 2026 · 24 likes post #63 is right about the mechanism and I think understates the practical bit. Foaming during reconstitution: bubbles in the solution are usually just air…
Packaging that arrived damaged: documenting it properly — a second dataset Replied, post #42 · Sourcing › Logistics · 20 Feb 2026 · 1 like On post #38 — agreed on the reasoning, with one qualification. Documentation after arrival: photograph the parcel and its contents on arrival. If something later turns…
[2026 update] A rising related-substance total over six months: degradation or method… Replied, post #35 · Analytics › Impurities & related substances · 14 Feb 2026 · 0 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
Seven-day rolling means and why weekly readings mislead — one year on Replied, post #33 · Outcomes › Progress reports · 11 Feb 2026 · 0 likes Measurement noise: day-to-day body mass varies by more than a kilogram on hydration, glycogen, and gut contents alone. A weekly reading is a single noisy sample of a…
Reading SURMOUNT-1 without the press release — one year on Replied, post #42 · Compounds › Tirzepatide · 28 Jan 2026 · 24 likes post #41 is right about the mechanism and I think understates the practical bit. I disagree with the reply above, and I think the disagreement is substantive rather…
Semaglutide half-life: where the 165 to 184 hour figure comes from Replied, post #98 · Compounds › Semaglutide · 20 Jan 2026 · 12 likes On alcohol: the labelling does not contraindicate it, but it raises gastric irritation risk and semaglutide already does that. There is no published interaction study…
Warfarin and altered intake: the monitoring argument — the long version Replied, post #92 · Practice › Interactions · 18 Jan 2026 · 17 likes Supplements and herbs: many have no established interaction. Some do. If you are taking something unusual, checking a reference (like a pharmacist) is more useful than…
Amylin receptor signalling and satiety — what changed since Replied, post #9 · Pharmacology › Receptor biology · 28 Dec 2025 · 0 likes Central versus peripheral action: GLP-1 agonism works through both central nervous system effects (appetite) and peripheral effects (gastric motility, insulin). The…
Second pass at: Metformin co-administration and additive GI effects Replied, post #22 · Practice › Interactions · 23 Dec 2025 · 6 likes Metformin: commonly co-administered and relevant to gastrointestinal tolerability. Gastrointestinal side effects can overlap and additive. Taking them separately or…
Waist circumference technique and its repeatability Replied, post #26 · Outcomes › Progress reports · 13 Dec 2025 · 0 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
Tracking a preprint to publication: a worked example Replied, post #65 · Evidence › Preprints · 6 Dec 2025 · 13 likes Server repositories: medRxiv for medicine, bioRxiv for biology. Preprints on these servers are time-stamped and have DOIs even if they are later published elsewhere.…
Water content on a certificate and why it changes the arithmetic — what changed since Replied, post #3 · Analytics › COA interpretation · 5 Dec 2025 · 0 likes Counter-ion form is crucial: peptides are isolated as salts, most often trifluoroacetate from reversed-phase purification or acetate after salt exchange. The…
Why a compound being unapproved is not the same as being illegal to possess Replied, post #36 · Sourcing › Regulatory · 28 Nov 2025 · 0 likes Coming back to post #34, because the follow-up matters more than the original answer. Off-label use and medical practice: clinicians can prescribe approved medications…
Documentation that materially improves an appeal's chances Replied, post #60 · Access › Insurance & coverage · 11 Nov 2025 · 20 likes I read post #58 twice before replying, because I had assumed the opposite. Tier placement and step therapy: some formularies place a medication on a higher tier or…
Research-use-only labelling: what it means and what it does not Replied, post #57 · Sourcing › Regulatory · 10 Nov 2025 · 14 likes Regulatory positions change: a compound's status today might differ from its status a year from now. Citing a regulatory position is worth doing only with a date…
History of disordered eating and why it changes the conversation Replied, post #18 · Clinical › Special populations · 19 Oct 2025 · 31 likes Older adults: sarcopenia risk is higher, polypharmacy is common, and the clinical trials did not enroll many people over 75. Extrapolating to very old people is…
A parcel that arrived warm: a decision process, not a verdict Replied, post #71 · Practice › Storage & stability · 6 Oct 2025 · 4 likes Dating prepared solutions: write the date reconstitution on the vial in permanent marker. If you later need to know whether it has been sitting for weeks or days, the…
The headache that turns out to be dehydration Replied, post #3 · Nutrition & Training › Hydration & electrolytes · 20 Sep 2025 · 2 likes Water intoxication: drinking excessive water (more than a few liters per day for extended time) without electrolyte replacement can cause hyponatremia. This is rare but…
Guidelines revision: what changed and why — one year on Replied, post #16 · Meta › Announcements · 15 Sep 2025 · 0 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
Documentation that appears only after payment Replied, post #13 · Sourcing › Red flags · 28 Aug 2025 · 19 likes Evasion when asked: if a supplier does not clarify when asked specifically for method details, counter-ion form, or batch origin, that itself is a red flag worth…
[2026 update] Journal club: is percentage weight change the right endpoint? Replied, post #85 · Evidence › Journal club · 22 Aug 2025 · 23 likes SURMOUNT-OSA (N Engl J Med 2024): Tirzepatide in obstructive sleep apnoea, using an objective physiological endpoint. Notable because soft endpoints are avoided. Two…
Follow-up: The lowest dose that does anything: is that a real question? Replied, post #38 · Practice › Dosing & titration · 5 Aug 2025 · 0 likes Holding a dose indefinitely: the trials did not study indefinite holding at a non-maximum dose. The trials escalated to a target and then held that. What happens if you…
Are there stupid questions here? A staff answer, at length Replied, post #38 · Start Here › Welcome · 4 Aug 2025 · 7 likes On post #34 — agreed on the reasoning, with one qualification. Nothing here requires expertise. The experienced members here got that way by posting questions, not by…
Coming back to: Amylin analogue mechanism: satiety signalling separate from GLP-1 Replied, post #18 · Compounds › Cagrilintide & amylin analogues · 20 Jul 2025 · 7 likes For anyone arriving from searches on "amylin agonist": this subcategory discusses published clinical evidence and what it does and does not establish. It does not…
Ipamorelin selectivity claims and where they came from Replied, post #54 · Compounds › Secretagogues & GH axis · 6 Jul 2025 · 0 likes Tesamorelin has an approved indication in HIV-associated lipodystrophy. That is the only compound in this class with a registration-quality evidence base from a proper…
Coming back to: What published stability data actually covers, and what it does not Replied, post #68 · Practice › Storage & stability · 20 Jun 2025 · 0 likes Dating prepared solutions: write the date reconstitution on the vial in permanent marker. If you later need to know whether it has been sitting for weeks or days, the…
Revisiting: Reading a denial letter as a specification for your appeal Replied, post #3 · Access › Insurance & coverage · 28 May 2025 · 0 likes Picking up post #2: that is the part I would want checked first. Reimbursement changes: a compound covered one year might not be the next. A formulary decision in…
[2026 update] Cardiovascular risk: reading the outcome trials as a set Replied, post #40 · Clinical › Comorbidities · 26 May 2025 · 33 likes post #39 answers the question as asked. The question underneath it is different. I disagree with the reply above, and I think the disagreement is substantive rather…
Validating a calculator against hand arithmetic — what changed since Replied, post #42 · Data & Tools › Calculators · 30 Apr 2025 · 20 likes Titration planning: a calculator that shows you the escalation schedule for different starting and ending doses can help you visualize your path. Actual path might be…
Why oral semaglutide needs an absorption enhancer at all — what changed since Replied, post #2 · marked as the solution · Compounds › Oral incretins · 24 Apr 2025 · 9 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
Second pass at: Reading a combination trial: attributing effect to components Replied, post #6 · Compounds › Cagrilintide & amylin analogues · 15 Apr 2025 · 7 likes Cagrilintide molecular characteristics: it is a synthetic amylin analogue, substituted to prevent the amyloidogenicity of human amylin. The sequence is short and…
Scheduled maintenance and what will be unavailable Replied, post #86 · Meta › Announcements · 26 Mar 2025 · 9 likes This follows post #83 rather than contradicting it. Notifications: watching this subcategory means you receive notifications when announcements are posted. Useful if…
One lot is one lot: when a report becomes a pattern — the long version Replied, post #15 · Sourcing › Vendor reports · 15 Mar 2025 · 4 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
Follow-up: Open-label extensions: what survives and what does not Replied, post #7 · Evidence › Trials · 7 Mar 2025 · 0 likes On post #3 — agreed on the reasoning, with one qualification. Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly…
What SELECT changed about how semaglutide is discussed, and what it did not Replied, post #16 · Compounds › Semaglutide · 19 Feb 2025 · 26 likes post #15 is right about the mechanism and I think understates the practical bit. Thank you for the correction. I have edited my earlier post with a note rather than…
Random versus fixed effects: choosing rather than defaulting — a second dataset Replied, post #91 · Evidence › Meta-analyses · 11 Feb 2025 · 27 likes On post #87 — agreed on the reasoning, with one qualification. Subgroup analysis: sometimes a meta-analysis reports separate pooled estimates for different subgroups…
How compounding permissions changed when supply normalised Replied, post #17 · Sourcing › Regulatory · 8 Feb 2025 · 10 likes Preclinical versus clinical: compounds with strong preclinical data can fail in clinical trials. Compounds with no human data are being used on theoretical grounds. The…
Coming back to: Preparing for an appointment: one page, three questions Replied, post #138 · Clinical › Prescriber conversations · 3 Jan 2025 · 2 likes Coming back to post #136, because the follow-up matters more than the original answer. Practical note that does not fit anywhere else. Whatever you conclude from this…
[2026 update] Journal club: SURPASS-2 and the semaglutide 1 mg comparator Replied, post #67 · Evidence › Journal club · 21 Dec 2024 · 0 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
A promotion I argued against, and why I lost Replied, post #28 · Documentation › Doc review · 12 Dec 2024 · 25 likes Review of promoted topics: when a topic is nominated for promotion to a maintained documentation page, the draft is posted here. Community review happens before…
Meeting a protein target on a suppressed appetite — does this still hold? Replied, post #23 · Nutrition & Training › Protein & intake · 26 Nov 2024 · 1 like This follows post #20 rather than contradicting it. For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add…
How to ask for a dose change without antagonising anyone — what changed since Replied, post #57 · Clinical › Prescriber conversations · 13 Nov 2024 · 11 likes On post #53 — agreed on the reasoning, with one qualification. Two things before anyone answers the substance. First, the context in the first post is clear and…
Revisiting: Moderation log format change Replied, post #17 · Meta › Announcements · 5 Nov 2024 · 0 likes Implementation timeline: announcements include when a change takes effect. Marking the date helps you know whether the change is already in effect.
Coming back to: Grapefruit: why this class is not the class that cares Replied, post #23 · Practice › Interactions · 4 Nov 2024 · 14 likes post #22 is right about the mechanism and I think understates the practical bit. Insulin interaction: semaglutide and tirzepatide are not contraindicated with insulin…
Promotion criteria, and the one that stops most nominations Replied, post #37 · Documentation › Doc review · 13 Aug 2024 · 30 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
Signs of dehydration worth acting on Replied, post #4 · Safety › Adverse events · 11 Aug 2024 · 0 likes the opening post is right about the mechanism and I think understates the practical bit. Acute kidney injury: rare but reported. Symptoms (decreased urine output,…
Oral contraceptives and delayed emptying: what the data shows Replied, post #40 · Practice › Interactions · 13 Jul 2024 · 0 likes Insulin interaction: semaglutide and tirzepatide are not contraindicated with insulin but the combination carries hypoglycemia risk if insulin doses are not adjusted.…
The mass-error checker and its intended scope Replied, post #38 · Data & Tools › Calculators · 9 Jun 2024 · 32 likes Worth separating two things that post #34 runs together. Dose equivalence calculator: compounds have different potencies. The calculator is provided with a caveat:…